15.69
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Is CeriBell Inc. a good long term investmentSuperior stock selection - jammulinksnews.com
What drives CeriBell Inc. stock priceHigh-profit capital plays - jammulinksnews.com
CeriBell Inc. Stock Analysis and ForecastSuperior stock growth - jammulinksnews.com
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Manila Times
What analysts say about CeriBell Inc. stockExceptional gains - printweek.in
How CeriBell Inc. stock performs during market volatilityReturn Optimized Trade Insights - Newser
Brokerages Set CeriBell, Inc. (NASDAQ:CBLL) Price Target at $32.14 - Defense World
What makes CeriBell Inc. stock price move sharplyFast Gains With Reduced Risk - Newser
Why CeriBell Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
CeriBell shares drop 38% following InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Ceribell sues Natus Medical for patent infringement - MSN
Ceribell, Inc.’s Strategic Positioning and Patent Strength Justify Buy Rating - TipRanks
Ceribell (CBLL) CEO Chao sells $442,500 in stock By Investing.com - Investing.com South Africa
Ceribell (CBLL) CEO Chao sells $442,500 in stock - Investing.com
Ceribell files patent infringement complaints against Natus Medical By Investing.com - Investing.com South Africa
Ceribell's IP Offense: How Legal Aggression Could Spark a Neurotech Breakout - AInvest
Ceribell files patent infringement complaints against Natus Medical - Investing.com Australia
Ceribell's Legal Offense and Pediatric Breakthrough: A Strategic Double Play for Market Dominance - AInvest
Ceribell Files Patent Infringement Complaints Against Natus - TipRanks
CeriBell Files Patent Infringement Complaints Against Natus Medical - MarketScreener
Ceribell sues Natus Medical for patent infringement (CBLL) - Seeking Alpha
Ceribell files complaints against Natus Medical, alleges patent infringement - TipRanks
CeriBell, Inc. Files Patent Infringement Complaints Against Natus Medical Incorporated - Nasdaq
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware - GlobeNewswire
Ceribell Hits Competitor With Patent Lawsuit Over Wearable EEG - Bloomberg Law News
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):